Ledger.Open graph →
SEC Form D · filed April 14, 2014

IMMUNE PHARMACEUTICALS INC

Offering
$11.7M
Sold
$11.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Rene G. Lerer · New York, NYDirectorAna G. Stancic · New York, NYDirectorDaniel G. Kazado · New York, NYDirectorDaniel G. Teper · New York, NYExec · DirectorDavid G. Sidransky · New York, NYDirectorIsaac G. Kobrin · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗